Meta‐analysis: the efficacy of over‐the‐counter gastro‐oesophageal reflux disease therapies

@article{Tran2007MetaanalysisTE,
  title={Meta‐analysis: the efficacy of over‐the‐counter gastro‐oesophageal reflux disease therapies},
  author={Thach Tran and A M Lowry and H. B. El‐Serag},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2007},
  volume={25}
}
Over‐the‐counter histamine‐2 receptor antagonists, antacids and alginate/antacids are commonly used for gastro‐oesophageal reflux disease. 
Economic evaluation of short‐term treatment of gastro‐oesophageal reflux in Peru
TLDR
Four alternatives for handling gastro‐oesophageal reflux (GER) from the pharmacoeconomic standpoint are analyzed: proton pump inhibitors, H2‐histamine receptor antagonists, antacids (AA) and alginates. Expand
[Alginates in therapy for gastroesophageal reflux disease].
TLDR
Evidence of the prevalence of gastroesophageal reflux disease (GERD) is presented and its main treatment options are highlighted and particular emphasis is laid on alginates and their main mechanisms of action. Expand
Post‐prandial reflux suppression by a raft‐forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH‐impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double‐blind study in reflux patients
Alginates form a raft above the gastric contents, which may suppress gastro‐oesophageal reflux; however, inconsistent effects have been reported in mechanistic and clinical studies.
New algorithm for the treatment of gastro‐oesophageal reflux disease
TLDR
This data indicates that among patients with GERD who are referred to a pharmacist or primary care physician after initial management fails, atypical symptoms such as acid reflux and constipation are more common than previously thought. Expand
Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self‐treating subjects
TLDR
Lansoprazole 15 mg is indicated for treatment of heartburn and other gastro‐oesophageal reflux disease‐related symptoms. Expand
New pharmacologic approaches in gastroesophageal reflux disease.
TLDR
Current and emerging pharmacological treatments for gastroesophageal reflux disease, opportunities for improving medical treatment, and the extent to which improvements may be achieved with current therapy are highlighted. Expand
New pharmacologic approaches in gastroesophageal reflux disease.
TLDR
Current and emerging pharmacological treatments for gastroesophageal reflux disease, opportunities for improving medical treatment, and the extent to which improvements may be achieved with current therapy are highlighted. Expand
Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors
TLDR
A proposed algorithm that details when and how to use available over-the-counter medications is presented, and highlights alarm features and atypical symptoms indicative of other underlying conditions that should be referred directly to a physician. Expand
Gastroesophageal Reflux Disease (GERD)
TLDR
This chapter guides the physician through the differential diagnosis of these causes, as well as the treatment and management as an outpatient of GERD. Expand
Mucosal Protective Compounds in the Treatment of Gastroesophageal Reflux Disease. A Position Paper Based on Evidence of the Romanian Society of Neurogastroenterology.
TLDR
Drugs used to protect the esophageal mucosa against acid are useful in alleviating chronic heartburn, especially in patients with mild reflux symptoms. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
On‐demand treatment of gastro‐oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo
To compare the effects of ranitidine 75 mg with those of either cimetidine 200 mg or placebo given on demand for relief of typical symptoms of gastro‐oesophageal reflux disease during a 15‐day period.
A double‐blind, placebo‐controlled study of the efficacy and safety of non‐prescription ranitidine 75 mg in the prevention of meal‐induced heartburn
: Ranitidine 75 mg (Zantac 75) has been shown to be effective for the treatment of pre‐existing heartburn symptoms.
Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn
The most frequent cause of episodic heartburn is food and beverage ingestion. Nizatidine, an H2‐receptor antagonist, is currently approved for non‐prescription use in the prevention and relief ofExpand
Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
  • H. Koelz
  • Medicine
  • Scandinavian journal of gastroenterology. Supplement
  • 1989
TLDR
H2-receptor antagonists, the present mainstay of reflux therapy, improve esophagitis, but they are insufficient in the treatment of severe esophgitis where omeprazole may become the therapy of choice. Expand
Low‐dose ranitidine for the relief of heartburn
TLDR
Treatments that decrease gastric volume as well as increase the pH of refluxed material should be more effective in relieving heartburn. Expand
Alginate-antacid in the reduction of gastro-oesophageal reflux.
TLDR
Significant reduction in the number of reflux episodes and percentage time during which the lower œsophageal pH was acid was noted in the gaviscon group after treatment, whereas no significant changes occurred in the other two groups. Expand
Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis.
TLDR
A low-dose antacid tablet regimen relieves symptoms significantly better than placebo in patients with reflux oesophagitis. Expand
H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
To ascertain through clinical and endoscopic assessment, the clinical benefits of using H2 antagonists to treat patients with reflux esophagitis, we researched the English language literature usingExpand
Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis
TLDR
It was found that the natural history of symptomatic reflux esophagitis was to improve with either antacid or placebo, and there was no significant difference in antacids or placebo on the (short-term) naturalHistory of the disease. Expand
Medical treatment of symptomatic hiatus hernia with low-density compounds.
SummaryTwenty-eight patients with hiatus hernia and severe symptoms of oesophageal reflux completed a double-blind cross-over trial in which compounds designed to float on gastric contents wereExpand
...
1
2
...